Sustained ventricular tachycardia in a thalidomide-treated patient with primary plasma-cell leukemia

Nature Clinical Practice Oncology

Volumn 4, Issue 12, 2007, Pages 722-725

  Ballanti, Stelvio ^a   Mastrodicasa, Elena ^a   Bolli, Niccolò ^a   Lotti, Flavia ^a   Capolsini, Ilaria ^a   Berchicci, Laura ^a   Merigiola, Carla ^b   Giordano, Giampiero ^b   Tabilio, Antonio ^c  

^a UNIVERSITY OF PERUGIA   (Italy)

^b Orvieto Hospital   (Italy)

^c UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BISPHOSPHONIC ACID DERIVATIVE; BORTEZOMIB; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DIURETIC AGENT; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; MESALAZINE; PREDNISONE; THALIDOMIDE; VINCRISTINE;

AGED; ARTICLE; BLOOD EXAMINATION; BLOOD SMEAR; BONE MARROW BIOPSY; CASE REPORT; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; HEART VENTRICLE TACHYCARDIA; HOLTER MONITORING; HUMAN; LEUKEMIA REMISSION; MAINTENANCE THERAPY; MALE; MULTIPLE CYCLE TREATMENT; PLASMA CELL LEUKEMIA; PRIORITY JOURNAL; SALVAGE THERAPY; SYNCOPE;

AGED; ANGIOGENESIS INHIBITORS; HUMANS; LEUKEMIA, PLASMA CELL; MALE; TACHYCARDIA, VENTRICULAR; THALIDOMIDE;

EID: 36549081004     PISSN: 17434254     EISSN: 17434262     Source Type: Journal    
DOI: 10.1038/ncponc1008     Document Type: Article

References (13)

1. International Myeloma Working Group (2003) Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: A report of the International Myeloma Working Group. Br J Haematol 121: 749-757
2. Kyle RA et al. (1974) Plasma cell leukemia: Report on 17 cases. Arch Intern Med 133: 813-818
3. Garcia-Sanz R et al. (1999) Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics. Blood 93: 1032-1037
4. Hayman SIR and Fonseca R (2001) Plasma cell leukemia. Curr Treat Options Oncol 2: 205-216
5. Saccaro S et al. (2005) Primary plasma cell leukemia: Report of 17 new cases treated with autologous or allogeneic stem-cell transplantation and review of the literature. Am J Hematol 78 288-294
6. Myeloma Trialists' Collaborative Group (2001) Interferon as therapy for multiple myeloma: An individual patient data overview of 24 randomized trials and 4,012 patients. Br J Haematol 113: 1020-1034
7. Thalidomide prescribing information (2006) (Celgene, Summit, NJ, USA)
8. Fahdi IE et al. (2004) Bradycardia during therapy for multiple myeloma with thalidomide. Am J Cardiol 93: 1052-1055
9. Johnston RE and Abdalla SH (2002) Thalidomide in low doses is effective for the treatment of resistant or relapsed multiple myeloma and for plasma cell leukaemia. Lymphoma 43: 351-354
10. Petrucci MT et al. (2007) Thalidomide does not modify the prognosis of plasma cell leukemia patients: Experience of a single center. Leuk Lymphoma 48: 180-182
11. Wohrer S et al. (2004) Effective treatment of primary plasma cell leukemia with thalidomide and clexamethasone - a case report. Hematol J 5: 361-363
12. Attal M et al. (2006) Maintenance therapy with thalidomide improves survival in patients with multiple myeloma. Blood 108 3289-3294
13. Musto P et al. (2007) Efficacy and safety of bortezomib in patients with plasma cell leukemia. Cancer 109: 2285-2290